Patents by Inventor Jean-Philippe Starck

Jean-Philippe Starck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE COMPARATIVE ANALYSIS OF PROTEIN PREPARATIONS BY MEANS OF NUCLEAR MAGNETIC RESONANCE
    Publication number: 20130069646
    Abstract: The invention relates to a method for the comparative analysis and control of the quality of a protein preparation by means of nuclear magnetic resonance (NMR) spectrometry. This method can be used to compare three-dimensional protein conformations in different protein preparations without requiring the samples to undergo any particular preparation. In particular, the method can be used to determine if a selected protein is in the same three-dimensional conformation in different protein preparations, if it is degraded in the formulation or if it is interacting with some of the excipients present. Specifically, the method can be used for the analysis and control of the quality of therapeutic compounds, particularly biodrugs or biosimilars, in different samples, without altering said samples.
    Type: Application
    Filed: December 30, 2010
    Publication date: March 21, 2013
    Applicant: NMRTEC
    Inventors: Jean-Philippe Starck, Bruno Kieffer, Marc Quinternet
  • Benzoxazolone derivatives, processes for preparing them and their uses
    Patent number: 8293775
    Abstract: The present invention relates to benzoxazolone derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals, in the treatment of movement disorders, in particular in Parkinson's disease.
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: October 23, 2012
    Assignee: UCB Pharma, S.A.
    Inventors: Jean-Philippe Starck, Benoît Kenda
  • Indolone-acetamide derivatives, processes for preparing them and their uses
    Patent number: 7964593
    Abstract: The present invention relates to indolone-acetamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as for the treatment of epilepsy, epileptogenesis, seizure disorders and convulsion.
    Type: Grant
    Filed: November 20, 2009
    Date of Patent: June 21, 2011
    Assignee: UCB Pharma, S.A.
    Inventors: Jean-Philippe Starck, Benoit Kenda
  • Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
    Publication number: 20100069375
    Abstract: The present invention relates to indolone-acetamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as for the treatment of epilepsy, epileptogenesis, seizure disorders and convulsion.
    Type: Application
    Filed: November 20, 2009
    Publication date: March 18, 2010
    Applicant: UCB PHARMA, S.A.
    Inventors: Jean-Philippe Starck, Benoit Kenda
  • Indolone-acetamide derivatives, processes for preparing them and their uses
    Patent number: 7645887
    Abstract: The present invention relates to indolone-acetamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as for the treatment of epilepsy, epileptogenesis, seizure disorders and convulsion.
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: January 12, 2010
    Assignee: UCB Pharma, S.A.
    Inventors: Jean-Philippe Starck, Benoît Kenda
  • Indolone Derivatives, Processes For Preparing Them And Their Uses
    Publication number: 20090012147
    Abstract: The present invention relates to indolone derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: July 14, 2005
    Publication date: January 8, 2009
    Applicant: UCB PHARMA, S.A.
    Inventors: Benoit Kenda, Jean-Philippe Starck
  • Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
    Patent number: 7361668
    Abstract: The invention concerns quinuclidine derivatives of formula I or II wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention show high affinities for m3 and/or m2 muscarinic receptors and are particularly suited for treating urinary incontinence.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: April 22, 2008
    Assignee: UCB, S.A.
    Inventors: Michel Guyaux, Chimmanamada U. Dinesh, Charles Mioskowski, Luc Quere, Jean-Philippe Starck, Patrice Talaga, Alain Wagner, Matteo Zanda
  • Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses
    Publication number: 20070299118
    Abstract: The present invention relates to benzoxazolone derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals, in the treatment of movement disorders, in particular in Parkinson's disease.
    Type: Application
    Filed: May 24, 2005
    Publication date: December 27, 2007
    Applicant: UCB, S.A.
    Inventors: Jean-Philippe Starck, Benoit Kenda
  • Indolone-acetamide derivatives, processes for preparing them and their uses
    Publication number: 20070043038
    Abstract: The present invention relates to indolone-acetamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as for the treatment of epilepsy, epileptogenesis, seizure disorders and convulsion.
    Type: Application
    Filed: March 16, 2004
    Publication date: February 22, 2007
    Applicant: UCB, S.A.
    Inventors: Jean-Philippe Starck, Benoit Kenda
  • Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
    Publication number: 20050020660
    Abstract: The invention concerns quinuclidine derivatives of formula I or II wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention_show high affinities for m3 and/or m2 muscarinic receptors and are particularly suited for treating urinary incontinence.
    Type: Application
    Filed: September 23, 2002
    Publication date: January 27, 2005
    Inventors: Michel Guyaux, Chimmanamada Dinesh, Charles Mioskowski, Luc Quere, Jean-Philippe Starck, Patrice Talaga, Alain Wagner, Mateo Zanda